For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...

Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...

Ensoma Announces $53 Million Financing to Support Key Clinical Milestones for EN-374 and Continued Development of In Vivo Hematopoietic Stem Cell Engineering Pipeline Company’s Phase 1/2 Clinical ...

Funded by the UB Provost, the new Center for Cell, Gene and Tissue Engineering (CGTE) will be led by SUNY Distinguished Professor Stelios Andreadis. “I am very happy to announce the launch of the Cell ...

Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that engineer cell fate ...

Mice with two male parents that lived to adulthood have been created by stem cell scientists. But the genetically engineered ...

UBC research associate Dr. Ross Jones in the lab where they are working to develop cell-based therapies from stem cells. Credit: Phillip Chin. For the first time, researchers at the University of ...

Company’s Phase 1/2 Clinical Trial of EN-374 in X-linked Chronic Granulomatous Disease is Now Open for Patient Enrollment BOSTON--(BUSINESS WIRE)-- Ensoma, an in vivo hematopoietic stem cell (HSC) ...